Good MorningInvestors and traders got a double-shot of good news from Fed chief Jerome Powell’s second day of testimony on Capitol Hill. In his comments, Mr. Powell both affirmed the need for more stimulus while also indicating the economic recovery is well underway. The pandemic is still a concern as are high levels of joblessness but the general outlook is positive. Add to that a lack of concern for the possibility of rising inflation and it is no surprise the broad market S&P 500 gained 1.0%.
Technically speaking, Wednesday’s gain in the market is a bullish signal. The market made a solid move higher confirming support at a key technical level, the 30-day moving average. The 30-day moving average is a gauge of near-term sentiment and an indication of which direction short-term traders are placing their bets. With the moving average trending higher and support at the average confirmed new all-time highs for the S&P 500 index are all but assured.
Featured: Is Elon's empire crumbling? (Ad) 
|
Markets | | | Wall Street’s mania over GameStop is on again, at least for one afternoon.
Shares in the troubled video game company more than doubled Wednesday to $91.71 apiece, the stock’s best day since Jan. 27, when it was going for $347.51 a share.
A rally in GameStop has been rar... Read the Full Story |
|
From Our Partners | | We’ve got seven great summertime plays for you. These stocks are in a prime position to reward your portfolio… especially if you take action before summer is in full swing!
They cover summer-centric industries such as solar, home improvement, entertainment, travel, and more.
To keep you motivated during these summer months, we’d like to give you a FREE report revealing these companies – 7 Best Stocks to Own in Summer 2025. | | Get Your Copy of "7 Best Stocks to Own in Summer 2025" Here. |
|
Markets | | | Investor Warren Buffett's right-hand man says the U.S. stock market is overvalued, but he doesn't know when the bubble will burst.
Billionaire Charlie Munger is a vice chairman at Buffett's Berkshire Hathaway conglomerate. He typically sits alongside Buffett to field questions at Ber... Read the Full Story |
|
Stocks | | |
Now that we’ve seen some volatility in February, it might be time to take a long hard look at your portfolio holdings. If you were feeling very uncomfortable during the recent market weakness, you might be overexposed to things like growth stocks or simply haven’t accurately defined yo... Read the Full Story |
|
From Our Partners | | Cold War Discovery Could Unlock $100 Trillion in Wealth
Jeff recently traveled to an American ghost town to investigate this crazy Cold War story…
Because it could hold the key to the entire $100 trillion AI boom.
It involves an American ghost town with just 30 people…
And a new twist to the AI boom that could make a lot of people rich. | | Click here to see the details on what could be the biggest tech story of this decade. |
|
Politics | | | A trust representing more than 80,000 victims of deadly wildfires ignited by Pacific Gas and Electric’s rickety electrical grid is suing nearly two dozen of the utility’s former executives and board members Read the Full Story |
|
Markets | | |
Plug Power (NASDAQ:PLUG) is among the electric vehicle stocks that have faced much of the recent market backlash surrounding technology valuations. With the EV space unplugged at the moment, some companies may be finding new homes at more palatable prices while others are simply recharging for the... Read the Full Story |
|
|
Politics | | | GENEVA — The World Health Organization’s Europe unit is reporting that about one in 10 people who contracted COVID-19 continue to show “persistent ill health” 12 weeks after infection.
Dr. Hans Kluge, the head of WHO Europe, says much about so-called “long COVID” remains unknown, but... Read the Full Story |
|
Markets | | | A public service ad campaign unveiled Thursday aims to convince Americans to get vaccinated against COVID-19, telling them “It's Up to You.”
The campaign by the Ad Council and its partners is focused on those who may be hesitant to get the shots. One print ad reads: “Getting back to h... Read the Full Story |
|
Markets | | | Square Rides Bitcoin To Triple-Digit Growth
Square (NASDAQ:SQ) is an up-and-coming fintech that is benefiting greatly from the shift to eCommerce spurred by the pandemic, and from renewed interest in cryptocurrency. The company, already growing at a significant clip, saw its revenue growth accelera... Read the Full Story |
|
Markets | | | Having watched shares drop as much as 12% from all-time highs in recent weeks, investors of Nvidia (NASDAQ: NVDA) got a big boost last night when the chipmaker released their Q4 earnings. GAAP EPS came in at $2.31, a full $0.33, or 15% Read the Full Story |
|
Markets | | | Medical services got a fundamental shift when Teladoc Health (NYSE:TDOC) came on the scene. With a pandemic in full swing, and medical professionals at least a little leery about being in the same room with patients, Teladoc was a godsend Read the Full Story |
|
The Early Bird Stock Of The Day Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas. | | View Today's Stock Pick |
|
